HomeMarketsU.S. Economy & JobsJohnson & Johnson (JNJ) Suspends Covid-19 Vaccine Sales Guidance
Johnson & Johnson (JNJ) Suspends Covid-19 Vaccine Sales Guidance

Johnson & Johnson’s (JNJ) worldwide sales increased by 5%, but strong dollar hurt them by about 2.9%, says Max Wassermann. He discusses how JNJ shares hit 52-week high today. He also goes over JNJ’s earnings highlights, as its Q revenue came in at $23.43B versus an estimated $23.75B. He then talks about how JNJ suspends its Covid-19 vaccine sales guidance. Tune in to find out more.

Trading 360

19 Apr 2022

ON AIR
education
10:30 pm
Your First Trade
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
ON AIR
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US